Sample Thesis Paper
Industry Rivalry in the case of Pfizer remains high with Merck & Co. Inc. and Novartis AG being significant rivals. The reason for high rivalry in the US Healthcare industry for Pfizer lies in the fact that there are a large number of pharmaceutical companies in the industry and since the Healthcare system is of an exceptional size, all of these companies manage to find the opportunities to sustain and develop themselves. Key rivals in the industry include Sandoz International GmbH Private, Watson Pharmaceuticals Inc., Barr Pharmaceuticals, Inc., King Pharmaceuticals Inc., Ranbaxy Laboratories Limited, Mylan, Inc., Johnson & Johnson, GlaxoSmithKline, and Sanofi-Aventis (Yahoo! Finance, 2009).
Another important aspect about the pharmaceutical industry that may have implications on rivalry in the healthcare industry in the future is the fact that industry trends are indicating an increased number of mergers and acquisitions in the next few years which may bring about exceptional changes in the industry in the form of stronger pharmaceutical companies.